Autopsy report · NCT01852916

NHFOV Versus NCPAP to Prevent Exubation Failure

“Poor recruitment rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Suspended: paused, and may or may not restart.
• 20 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

University of Manitoba

Sponsor type

University, hospital or other

Conditions

Respiratory Distress Syndrome

Interventions

CPAP; NHFOV

Participants

20 (planned, not actual)

Sites

2

Countries

Canada

Trials that died the same way

• Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy
  “low recruitment rate” (95% match in meaning)
• BicepsTenodesis vs. Biceps Debridement in Combined RC Tears and SLAP Lesions
  “Due to low recruitment rate” (89% match in meaning)
• Transcranial Magnetic Stimulation for Bipolar Depression
  “Poor recruitment” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.